Clinical Trial Update: MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 1/2 study of pembrolizumab (MK-3475) in combination with gemcitabine for non-small cell lung cancer. Results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Providence Health & Services | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-01-29